Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...